Cargando…
The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis
Chronic inflammation is one of the main determinants of atherogenesis. The traditional medications for treatment of atherosclerosis are not very efficient in targeting atherosclerotic inflammation. Most of these drugs are non-selective, anti-inflammatory and immunosuppressive agents that have advers...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769786/ https://www.ncbi.nlm.nih.gov/pubmed/31455044 http://dx.doi.org/10.3390/biom9090416 |